Clinical Trial Update: A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zoledronic acid in patients with myelofibrosis with myeloid metaplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myeloid Metaplasia

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Myelofibrosis, Myeloid Metaplasia | Phase 2 | Status: COMPLETED